Other studies yielded contradictory results regarding the influence of EPHB2 expression in breast cancer pathogenesis, with Wu et al linking its overexpression to decreased OS and DFS [31], and another group of researchers associating it with improved patient prognosis [30]. This evidence concerns the gene EPHB2 and breast carcinoma.